Der blev også observeret effekt hos mere alvorligt depressive patienter (baseline HAM- D ≥ 25) i alle positive placebokontrollerede forsøg.
Efficacy was also observed in more severely depressed patients (baseline HAM-D ≥ 25) in all positive placebo-controlled studies.